all report title image
  • Published In : Jul 2024
  • Code : CMI227
  • Pages : 180
  • Formats :
      Excel/PDF
  • Industry : Medical Devices

Respiratory inhalers are medical devices used for administration of drugs to treat respiratory diseases like asthma and COPD. These help to deliver the required dosage of medication directly to the airways through inhalation. Rising prevalence of respiratory diseases due to environmental factors, growing geriatric population susceptible to such conditions, and increasing awareness about inhaler therapies can drive the market growth. Advancements in inhaler drug delivery technologies, development of smart and digital inhalers, and introduction of combo inhalers with improved efficacy can also drive the market growth. However, high treatment costs and lack of availability in rural regions may hamper its widespread adoption.

Market Dynamics:

Global respiratory inhalers market growth is primarily driven by growing prevalence of respiratory diseases worldwide. Asthma and COPD incidence has increased dramatically in recent decades due to rising pollution levels, changing lifestyle trends, and aging population. As per data from WHO, around 300 million people currently suffer from asthma while over 200 million have COPD. Early diagnosis and availability of effective inhaler therapies have improved the treatment outlook of these conditions. Lack of awareness in low-income nations and high costs of branded drugs in some countries can hamper the market growth. However, ongoing R&D into newer categories of respiratory medicines, integration of digital technology into devices, and development of hybrid inhalers combining attributes of different types of inhalers can overcome these challenges by making effective treatment more affordable and accessible to patients.

Key Features of the Study:

- This report provides in-depth analysis of the global respiratory inhalers market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year

- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

- It profiles key players in the global respiratory inhalers market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies

- Key companies covered as a part of this study include GlaxoSmithKline, Merck, Boehringer Ingelheim, AstraZeneca, 3M, Teva Pharmaceutical, and Sunovion Pharmaceuticals

- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

- Global respiratory inhalers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global respiratory inhalers market

Detailed Segmentation-

  • By Type
    • Manually Operated
    • Digitally Operated
  • By Product
    • Dry Powder Inhaler
    • Metered Dose Inhaler
    • Others
  • By Application
    • Asthma
    • Chronic Obstructive Pulmonary Disease (COPD)
    • Arterial Hypertension
    • Other
  • By Region           
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Koninklijke Philips N.V.
    • General Electric Healthcare
    • ResMed Inc.
    • Fisher & Paykel Healthcare
    • Medtronic
    • Boehringer Ingelheim
    • GlaxoSmithKline plc
    • AstraZeneca
    • Novartis AG
    • Teva Pharmaceutical Industries Ltd.
    • Mylan N.V.
    • Roche Holding AG
    • Johnson & Johnson
    • Sanofi S.A.
    • Merck & Co., Inc.
    • Hoffmann-La Roche Ltd
    • Otsuka Pharmaceutical Co., Ltd.
    • Cipla Limited

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Type
      • Market Snapshot, By Product
      • Market Snapshot, By Application
      • Market Snapshot, By End User
      • Market Snapshot, By Region
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunities
    • Impact Analysis
    • Market Trends
    • Key Developments
    • Regulatory Scenario
    • Acquisitions and Partnerships Scenario
    • Funding and Investments
    • PEST Analysis
    • Porter’s Analysis
  4. Global Respiratory Inhalers Market- Impact of Coronavirus (COVID-19) Pandemic
    • Overall Impact
    • Government Initiatives
    • COVID-19 Impact on the Market
  5. Global Respiratory Inhalers Market, By Type, 2019 – 2031, (USD Bn)
    • Overview
      • Market Share Analysis, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, 2019 – 2031
      • Segment Trends
    • Manually Operated
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Digitally Operated
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
  6. Global Respiratory Inhalers Market, By Product, 2019 – 2031, (USD Bn)
    • Overview
      • Market Share Analysis, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, 2019 – 2031
      • Segment Trends
    • Dry Powder Inhaler
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Metered Dose Inhaler
      • Mammography
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Others
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
  7. Global Respiratory Inhalers Market, By Application, 2019 – 2031, (USD Bn)
    • Overview
      • Market Share Analysis, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, 2019 – 2031
      • Segment Trends
    • Asthma
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Chronic Obstructive Pulmonary Disease (COPD)
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Arterial Hypertension
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Others
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
  8. Global Respiratory Inhalers Market, By End User, 2019 – 2031, (USD Bn)
    • Overview
      • Market Share Analysis, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, 2019 – 2031
      • Segment Trends
    • Hospitals & Clinics
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Respiratory Care Center
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Academic and Research Institutes
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Others
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
  9. Global Respiratory Inhalers Market, By Region, 2019 – 2031, (USD Bn)
    • Introduction
      • Market Share Analysis, By Region, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, For Region, 2019–2031
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 – 2031, (USD Bn)
        • North Africa
        • Central Africa
        • South Africa
  10. Competitive Landscape
    • Company Profiles
      • Koninklijke Philips N.V.
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • General Electric Healthcare
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • ResMed Inc.
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Fisher & Paykel Healthcare
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Medtronic
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Boehringer Ingelheim
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • GlaxoSmithKline plc
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • AstraZeneca
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Novartis AG
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Teva Pharmaceutical Industries Ltd.
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Mylan N.V.
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Roche Holding AG
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Johnson & Johnson
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Sanofi S.A.
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Merck & Co., Inc.
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Hoffmann-La Roche Ltd
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Otsuka Pharmaceutical Co., Ltd.
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Cipla Limited
        • Company Highlights
        • Method Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
  11. Analyst Recommendations
    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map
  12. References and Research Methodology
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 32 market data tables and 28 figures on "Respiratory Inhalers Market” -Global forecast to 2031

View Our Licence Options

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered

860519526

Clutch
Credibility and Certification
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.